That's thanks to the results of a study showing the same, and potentially higher, efficacy of the new oral weight loss pills than competitor Novo Nordisk's popular Ozempic injection.
This is great news as it makes taking it easier and, for many, more affordable. However, the tablet will be further tested, but I think there is huge... Read more
I see that even if the covid ball is not solved so nice numbers cg to everyone who holds 💪 yesterday a lot of titles showed us that they are not written off yet
This company focuses and specializes in the development and research of immunotherapeutic drugs targeting the treatment of cancer and infectious diseases.
It is also known for the development and production of the COVID-19 vaccine with Pfizer.
Focus, specialization : production of drugs for humans and animals and the company also focuses on fighting various diseases such as : cancer, diabetes or Alzheimer's disease.
Products : Viagra or the vaccine against COVID-19.
After today's $PFE results, investors are likely to be tough on even competitor $CVS, which will report its results tomorrow before the market opens. So I expect a pullback, which I will use to increase my position. Anything around $70 is a nice price in my opinion. In fact, I don't think $CVS should come up with surprisingly good results.
I don't follow pharmaceutical companies much. Occasionally you can find nice ones that come up with a discovery (drug, method). Unfortunately, I've been burned by such startups. I don't know $CVS but I might look into a pharmaceutical company.
We use cookies to improve your experience on our site.
I'd be very interested to know how this is supposed to work... this would be a huge improvement! Finally, chocolate without regrets! :-D